[go: up one dir, main page]

Marra et al., 1990 - Google Patents

Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.

Marra et al., 1990

Document ID
16857774746443702093
Author
Marra M
Wilde C
Griffith J
Snable J
Scott R
Publication year
Publication venue
The Journal of Immunology

External Links

Snippet

Neutrophil granules contain proteins important in host defense against bacterial pathogens. Granule proteins released from activated neutrophils facilitate opsonization, phagocytosis, tissue digestion, and antimicrobial activity. Three similar, if not identical, neutrophil proteins …
Continue reading at academic.oup.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1712—Not used, see subgroup
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Similar Documents

Publication Publication Date Title
Marra et al. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
US5089274A (en) Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders
Marra et al. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
US5171739A (en) Treatment of endotoxin-associated shock and preventation thereof using a BPI protein
US5334584A (en) Recombinant, non-glycosylated bpi protein and uses thereof
Shamova et al. Purification and properties of proline-rich antimicrobial peptides from sheep and goat leukocytes
EP0610445B1 (en) Use of compositions comprising a bactericidal/permeability increasing protein and a lipid carrier
US5308834A (en) Treatment of endotoxin-associated shock and prevention thereof using a BPI protein
Ooi et al. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
Hieshima et al. CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity
Ramanathan et al. Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity
Weinrauch et al. Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate.
Levy Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents
Elsbach et al. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide
de Haas et al. A synthetic lipopolysaccharide-binding peptide based on amino acids 27–39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood
Kocher et al. Functional chemotactic factor CP-10 and MRP-14 are abundant in murine abscesses
DE69431922T2 (en) GLYCOSILIZED AND NONGLYCOLIZED BACTERICIDES / PERMEABILITY INCREASING PROTEINS AND METHODS FOR THEIR PRODUCTION
Hellman et al. Antiendotoxin strategies
Ohno LPS binding proteins in granulocyte lysosomes
Warren et al. Protective Efficacy of CAP18106–138–Immunoglobulin G in Sepsis
US5489676A (en) Polypeptides that potentiate bactericidal/permeability-increasing protein and methods for treating bacterial infections
CA2323630A1 (en) Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections
Marra et al. Regulation of the response to bacterial lipopolysaccharide by endogenous and exogenous lipopolysaccharide binding proteins
Elsbach Recent advances in therapy of sepsis: focus on recombinant bactericidal/permeability-increasing protein (BPI)
Krijgsveld Thrombocidins, microbicidal proteins of human blood platelets